IGIM
ACAD icon

I.G. Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

I.G. Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.32M Hold
35,000
– – 0.01% 285
2017
Q2 		$976K Buy
+35,000
New +$1.04M 0.01% 341
2016
Q4 		– Sell
-30,000
Closed -$954K – 396
2016
Q3 		$954K Buy
+30,000
New +$1.02M ﹤0.01% 663

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

I.G. Investment Management's ACAD Position: Q3 2017 in Review

I.G. Investment Management held its Acadia Pharmaceuticals (ACAD) position steady in Q3 2017 at 35,000 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #285.

I.G. Investment Management first reported a position in ACAD in Q3 2016 and has held it in 3 quarters since. 212 funds tracked by Wall St. Rank hold ACAD as of Q3 2017.

  • I.G. Investment Management held 35,000 shares of Acadia Pharmaceuticals worth $1.32M as of Q3 2017.
  • I.G. Investment Management left its Acadia Pharmaceuticals share count unchanged in Q3 2017.
  • Acadia Pharmaceuticals made up 0.01% of I.G. Investment Management's portfolio in Q3 2017, its #285 holding.
  • I.G. Investment Management first reported a position in Acadia Pharmaceuticals in Q3 2016 and has held it in 3 quarters since.
  • 212 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2017.

Based on I.G. Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.